Skip to content
Screener

LivaNova LIVN Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B-0.4%
Haemonetics logo
HaemoneticsHAE
45.7M-5.5%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
33.7M+7.1%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
28.7M-5.3%
Medtronic logo
MedtronicMDT
1.3B-0.1%
ITG
Integer HoldingsITGR
34.4M+1.5%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income (loss) before income tax18,47933,32045,964(282,326)
Income tax (benefit) expense(90,204)6,151(85,864)17,807
Loss from equity method investments(114)(8)(965)(28)
Net income (loss)$108,569$27,161$130,863$(300,161)
Basic earnings (loss) per share$1.98$0.50$2.39$(5.51)
Diluted earnings (loss) per share$1.93$0.50$2.33$(5.51)
Basic weighted average shares outstanding54,97154,57754,83154,502
Diluted weighted average shares outstanding56,27054,70856,10954,502

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's shares (diluted)?
LivaNova (LIVN) reported shares (diluted) of 56.3M in Q2 2026.
How has LivaNova's shares (diluted) changed year-over-year?
LivaNova's shares (diluted) increased by 2.9% year-over-year, from 54.7M to 56.3M.
What is the long-term trend for LivaNova's shares (diluted)?
Over 4 years (2021 to 2025), LivaNova's shares (diluted) has grown at a 2.3% compound annual growth rate (CAGR), from 199.9M to 218.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about LivaNova's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude